標普道瓊斯指數公佈2024年12月季度再平衡
Clarity Pharmaceuticals Ltd:清潔通知
Clarity Pharmaceuticals Ltd:證券報價申請-CU6
Clarity Pharmaceuticals Ltd:SARTATE試驗的最後一次患者評估已完成
Clarity Pharmaceuticals Ltd:前 2 名參與者在 co-PSMA 中服用了 Cu-64 SAR-bispSMA
Clarity Pharmaceuticals Ltd:董事權益變動-所有董事
Clarity Pharmaceuticals Ltd:關於未上市證券的通知-CU6
Clarity Pharmaceuticals Ltd:會議結果
Clarity Pharmaceuticals Ltd:主席致辭 AGM
Clarity Pharmaceuticals Ltd:AgM 總經理演講
Clarity Pharmaceuticals Ltd:使用 SAR-bispsma 進行正面交鋒
Clarity Pharmaceuticals Ltd:Clarity 和 Nucleus radioPharma 標誌 MSA
Clarity Pharmaceuticals Ltd:CMS 關於無線電診斷報銷政策的最終規則
Clarity Pharmaceuticals Ltd:關於未上市證券的通知-CU6
Clarity Pharmaceuticals Ltd:季度活動/附錄 4C 現金流報告
Clarity Pharmaceuticals Ltd:清潔通知
Clarity Pharmaceuticals Ltd:證券報價申請-CU6
Clarity Pharmaceuticals Ltd:年度股東大會通告/代表委任表格
Clarity Pharmaceuticals Ltd:清潔通知
Clarity Pharmaceuticals Ltd:證券報價申請-CU6